BRIDGEWATER, N.J., Feb. 27, 2019 /PRNewswire/ — The U.S. Food
Read moreFDA Expands Indication for Soliqua 100/33 (insulin glargine and lixisenatide injection) to Include Type 2 Diabetes Patients Uncontrolled on Oral Antidiabetic Medicines

mybestmedicine.com
Home »
BRIDGEWATER, N.J., Feb. 27, 2019 /PRNewswire/ — The U.S. Food
Read moreOctober 5, 2018 — The U.S. Food and Drug Administration
Read more(HealthDay)—After the expanded coverage provisions of the Affordable Care Act
Read more